Design Therapeutics, Inc. DSGN Earnings yield
Earnings yield at other companies
Other financials
Where this comes from
Calculated from Design Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Design Therapeutics, Inc.’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Design Therapeutics, Inc.'s earnings yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Design Therapeutics, Inc.'s earnings yield?
- Design Therapeutics, Inc. (DSGN) reported earnings yield of -10.6% in Q1 2026.
- How has Design Therapeutics, Inc.'s earnings yield changed year-over-year?
- Design Therapeutics, Inc.'s earnings yield increased by 58.6% year-over-year, from -25.6% to -10.6%.
- What is the long-term trend for Design Therapeutics, Inc.'s earnings yield?
- Over 4 years (2021 to 2025), Design Therapeutics, Inc.'s earnings yield has grown at a 44.6% compound annual growth rate (CAGR), from -3% to -13.1%.
- What does earnings yield mean?
- Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.